Anti-NMDA receptor encephalitis primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 12: | Line 12: | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
<ref name="pmid28106787">{{cite journal| author=Wang H| title=Anti-NMDA Receptor Encephalitis and Vaccination. | journal=Int J Mol Sci | year= 2017 | volume= 18 | issue= 1 | pages= | pmid=28106787 | doi=10.3390/ijms18010193 | pmc=5297824 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28106787 }} </ref> | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 17:20, 13 May 2023
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis primary prevention On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis primary prevention |
|
Anti-NMDA receptor encephalitis primary prevention in the news |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] AE Dheeraj Makkar, M.D.[2]
Overview
Primary Prevention
References
- ↑ Wang H (2017). "Anti-NMDA Receptor Encephalitis and Vaccination". Int J Mol Sci. 18 (1). doi:10.3390/ijms18010193. PMC 5297824. PMID 28106787.